Z-1484-2023 Class I Ongoing
FDA device recall Z-1484-2023 was initiated by Cordis US Corp on Mar 24, 2023 and is designated Class I. Reason for recall: There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous… The recall status is ongoing. Affected quantity: 684 units.
Recall details
- Product Type
- Devices
- Report Date
- May 17, 2023
- Initiation Date
- Mar 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 684 units
Product description
ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814RMC
Reason for recall
There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.
Distribution pattern
Worldwide distribution.
Code information
UDI/DI 20705032054802; Lot Numbers: 35264208, 35264212, 35265329, 35265654, 35265649, 35265667.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1484-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026